Navigation Links
Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
Date:11/18/2008

PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.

Fluoxetine Capsules, indicated for the treatment of premenstrual dysphoric disorder (PMDD) are the generic version of Eli Lilly's Sarafem(R) Pulvules(R) Capsules. This product had annual U.S. sales of approximately $19.2 million for the 12 months ending Sept. 30, 2008, for the noted strengths, according to IMS Health. Shipment of the product will begin immediately.

Currently, Mylan has 112 ANDAs pending FDA approval, 23 of which are potential first-to-file opportunities.

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
2. Mylan Declares Quarterly Preferred Stock Dividend
3. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
4. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
5. Mylan to Offer $400 Million in Cash Convertible Notes
6. Mylan Creates New Womens Health Care Franchise; Signs Agreement with Famy Care to Develop and Supply 22 Oral Contraceptive Products
7. Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
8. Mylan Declares Quarterly Preferred Stock Dividend
9. Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008
10. Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
11. Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...July 3 Republicans on t...ge in health care reform legislation that would el...ppens, many women could lose coverage for abortion...ncludes. Plus, millions of uninsured women will st...g been promised a better quality of life. , , I...
(Date:7/3/2009)... A new urine drug test kit called DrugCon...r individuals that want a fast and accurate instan...BioSciences, the cup has a sleek, innovative desig...rsquo;s also very competitively priced compared to...eing sold on the market , ...
(Date:7/3/2009)... "This is an opportunity for you to ...ur Diabetic Free pills, you will experience a noti...s: your blood sugar, cholesterol levels and blood ...revitalized and your mind will finally be freed fr...a diabetes patient." , ...
(Date:7/3/2009)... As the health care reform details emerge...surance for small groups and business insurance pr... turning to websites such as the Small Business He... Minneapolis, Minn. (PRWEB) July...considered by the House, which has entrepreneurs w...
Breaking Medicine News(10 mins):Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3
...is 50 suffers from severe back pain but she has to...a specialist. // It is not her fault but she is a...fficials are refusing to rectify. The extra delay ... in the Scottish Executive's waiting list figures....
... be no conclusive proof that consuming additional ...rs from the American Cancer Society//. This is fur...utrition. Though many medical specialists still pr...aining all round health, Eric Jacobs, senior epide...
... have discovered that fatty acid ethyl esters (FAE...ray the extent of fetal alcohol exposure//. "Ther...fant has been exposed to alcohol during pregnancy,...sociated with alcohol use," said Enrique M. Ostrea...
...ds immense promise for kids infected with Rotaviru...causing half a million deaths// amongst youngsters...lso received the approval from the FDA for its use...ons in children. A team of Researchers at the Rom...
Other Medicine News:
(Date:7/1/2009)...1 The largest study of,...revealed several new common,single-letter variant...d to,risk of the disease. The study, by a multina...m deCODE genetics (Nasdaq: DCGN ), analyzed the g...articipants from fourteen countries.,It is publis...
(Date:6/30/2009)...Newswire/ -- If you have been eating Garlic to kee... While there is absolutely no scientific evidence..., spraying garlic has plenty of evidence to prove ...t on grassy lawns is not as strange as it seems. M...bs, Inc. is being used successfully by city parks,...
(Date:6/30/2009)...e/ -- Accumetrics, Inc. announces that it has reac...lment of its landmark clinical trial, GRAVITAS ( G...ay I mpact on T hrombosis A nd S afety). The ...value of providing clinicians with actionable info...opidogrel (Plavix(R)). The multi-center, placebo ...
(Date:6/30/2009)...e/ -- Calixa Therapeutics Inc. today announced the... in patients with complicated urinary tract infect... cephalosporin antibiotic with excellent in vitro...ginosa , including drug resistant isolates. Calix...t for serious bacterial infections in hospitalized...
Breaking Medicine Technology:deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2VA NIH Study Offers Hope for Parkinsons Patients 3704 1VA NIH Study Offers Hope for Parkinsons Patients 3704 2VA NIH Study Offers Hope for Parkinsons Patients 3704 3S 26R Communications Group Partners With Ovation Pharmaceuticals to Launch Xenazine 28tetrabenazine 29 33804 1Grocery Manufacturers Association Releases Science Policy Paper on Sodium and Salt 33802 1Grocery Manufacturers Association Releases Science Policy Paper on Sodium and Salt 33802 2OpusMobility 28R 29 Clinical Information System Runs on Google G1 Smart Phone 33799 1OpusMobility 28R 29 Clinical Information System Runs on Google G1 Smart Phone 33799 2OpusMobility 28R 29 Clinical Information System Runs on Google G1 Smart Phone 33799 3
...n.--(BUSINESS WIRE)--May 14, 2007 - NanoViricides,...lts of recent,animal studies against rabies that w...tro studies against a Clade 2 H5N1 virus at,the 23...r Clinical,Virology in Tampa, FL, on Wednesday, Ma...PASCV): Clinical Virology Symposium), The animal s...
... 14, 2007 /PRNewswire-FirstCall/ -- Shire plc ,th...t/Hyperactivity,Disorder (ADHD), announced that it...tment portfolio at the American Psychiatric,Associ... in San,Diego. , "The upcoming clinical research t... to understanding the science of ADHD treatment,",...
Other Medicine Technology:Global Rabies Treatment May be Possible with NanoViricides Drugs 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 3Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 4Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 5Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 6Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 7
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use.
...irectly to the biopsy site helps to identify where...reg; II Tissue Marker is the only marker specifica... Biopsy System. It accurately, permanently, and ra...e MAMMOTOME System. The MICROMARK II Tissue Marker...
...YL knitted mesh. Especially suitable for injuries ...ble absorption. Polyglactin 910 has been found to ... (polyglactin 910) woven mesh is prepared from a s...tide, derived respectively from glycolic and lacti...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: